General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bristol-Meyers Squibb(MODEST), Merck(MODEST), sanofi-aventis(MODEST), Pfizer(MODEST), Novartis(MODEST), boeringer-ingelheim(SIGNIFICANT), Janssen Pharamaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Pfizer Inc(NONE), BMS(NONE), Blue Cross/Blue Shield of Michigan(NONE), Fibromuscular Disease Society of America(NONE)

View Full Disclosure